topic: Access to Medicines
COVID-19: MSF welcomes WHO solidarity call to action to share COVID-19 technology and intellectual property
US trade report could be used to block countries from making affordable COVID-19 medicines
COVID-19: MSF calls for no patents or profiteering on COVID-19 drugs, tests, and vaccines
5 barriers from Big Pharma preventing people getting lifesaving TB drugs
Access to medicines: MSF demands review of USTR Special 301 report on trade barriers
MSF: Global vaccines community must urgently support roll out of new more affordable pneumonia vaccine
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
Access to medicines: Gavi must ensure more children get new, more affordable pneumonia vaccine
MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumonia vaccine
